About Circumcision

About Circumcision

Circumcision consists of the surgical removal of some, or all, of the foreskin (or prepuce) from the penis. It is one of the most common procedures in the world. In the United States, the procedure is commonly performed during the newborn period. In 2007, the American Academy of Pediatrics (AAP) convened a multidisciplinary workgroup of AAP members and other stakeholders to evaluate the evidence regarding circumcision and update the AAP’s 1999 recommendations in this area. The Task Force included AAP representatives from specialty areas as well as members of the AAP Board of Directors and liaisons representing the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, and the Centers for Disease Control and Prevention. The Task Force members identified selected topics relevant to circumcision and conducted a critical review of peer-reviewed literature by using the American Heart Association’s template for evidence evaluation.

Evaluation of current evidence indicates that the health benefits of newborn circumcision outweigh the risks; furthermore, the benefits of newborn circumcision justify access to this procedure for families who choose it. Specific benefits from circumcision were identified for the prevention of urinary tract infections, acquisition of HIV, transmission of some sexually transmitted infections, and penile cancer. Circumcision does not appear to adversely affect penile sexual function/sensitivity or sexual satisfaction. It is imperative that those providing circumcision are adequately trained and that both sterile techniques and effective pain management are used. Significant acute complications are rare. In general, untrained providers who perform circumcisions have more complications than well-trained providers who perform the procedure, regardless of whether the former are physicians, nurses, or traditional religious providers.

Parents are entitled to factually correct, nonbiased information about circumcision and should receive this information from clinicians before conception or early in pregnancy, which is when parents typically make circumcision decisions. Parents should determine what is in the best interest of their child. Physicians who counsel families about this decision should provide assistance by explaining the potential benefits and risks and ensuring that parents understand that circumcision is an elective procedure. The Task Force strongly recommends the creation, revision, and enhancement of educational materials to assist parents of infants with the care of circumcised and uncircumcised penises. The Task Force also strongly recommends the development of educational materials for providers to enhance practitioners’ competency in discussing circumcision’s benefits and risks with parents.

The Task Force made the following recommendations:

• Evaluation of current evidence indicates that the health benefits of newborn circumcision outweigh the risks, and the benefits of newborn circumcision justify access to this procedure for those families who choose it.
• Parents are entitled to factually correct, nonbiased information about circumcision that should be provided before conception and early in pregnancy, when parents are most likely to be weighing the option of circumcision of a child.
• Physicians counseling families about elective circumcision should assist parents by explaining, in a nonbiased manner, the potential benefits and risks and by ensuring that they understand the elective nature of the procedure.
• Parents should weigh the health benefits and risks in light of their own religious, cultural, and personal preferences, as the medical benefits alone may not outweigh these other considerations for individual families.
• Parents of newborn boys should be instructed in the care of the penis, regardless of whether the newborn has been circumcised or not.
• Elective circumcision should be performed only if the infant’s condition is stable and healthy.
• Circumcision should be performed by trained and competent practitioners, by using sterile techniques and effective pain management.
• Analgesia is safe and effective in reducing the procedural pain associated with newborn circumcision; thus, adequate analgesia should be provided whenever newborn circumcision is performed.
  • Nonpharmacologic techniques (eg, positioning, sucrose pacifiers) alone are insufficient to prevent procedural and postprocedural pain and are not recommended as the sole method of analgesia. They should be used only as analgesic adjuncts to improve infant comfort during circumcision.
  • If used, topical creams may cause a higher incidence of skin irritation in low birth weight infants, compared with infants of normal weight; penile nerve block techniques should therefore be chosen for this group of newborns.
• Key professional organizations (AAP, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American Society of Anesthesiologists, the American College of Nurse Midwives, and other midlevel clinicians such as nurse practitioners) should work collaboratively to:
  • Develop standards of trainee proficiency in the performance of anesthetic and procedure techniques, including suturing;
  • Teach the procedure and analgesic techniques during postgraduate training programs;
  • Develop educational materials for clinicians to enhance their own competency in discussing the benefits and risks of circumcision with parents;
  • Offer educational materials to assist parents of infants with the care of both circumcised and uncircumcised penises.
• The preventive and public health benefits associated with newborn circumcision warrant third-party reimbursement of the procedure.

The American College of Obstetricians and Gynecologists has endorsed this technical report.

KEY WORDS

1. Howard CR, Howard FM, Garfunkel LC, de Blieck EA, Weitzman M. Neonatal circumcision and pain relief: current training practices. Pediatrics. 1998;101:423428.
2. Taddio A, Stevens B. Craig K, et al. Efficacy and safety of lidocaine-prilocaine cream for pain during neonatal circumcision. N Eng/ J Med. 1997;336:1197-1201.
3. Kirya C, Werthmann MW Jr. Neonatal circumcision and penile dorsal nerve block: a painless procedure. J Pediatr. 1978;92:998-1000.
4. Holve RL, Bromberger PJ, Groveman HD, Klauber MR, Dixon SD, Snyder JM. Regional anesthesia during newborn circumcision. Clin Pediatr. 1983;22:813-818.
5. Stang HJ, Gunnar MR, Snellman L, Condon LM, Kestenbaum R. Local anesthesia for neonatal circumcision: effects on distress and cortisol response. JAMA. 1988:259:1507-1511.
6. Lander J, Brady-Fryer B, Metcalfe JB, Nazarali S, Muttitt S. Comparison of ring block, dorsal penile nerve block, and topical anesthesia for neonatal circumcision: a randomized controlled trial. JAMA. 1997;278:2157-2162.
7. Blass EM. Hoffmeyer LB. Sucrose as an analgesic for newborn infants. Pediatrics. 1991,87:215-218.
8. Herschel M, Khoshnood B, Ellman C. Maydew N, Mittendorf R. Neonatal circumcision: randomized trial of a sucrose pacifier for pain control. Arch PediatrAdolesc Med. 1998,152:279-284.
9. Howard CR, Howard FM, Weitzman ML. Acetaminophen analgesia in neonatal circumcision: the effect on pain. Pediatrics. 1994;93:641-646.
10. Stang HJ, Snellman LW, Condon LM, et al. Beyond dorsal penile nerve block: a more humane circumcision. Pediatrics. 1997:100:e3. Available at: www .pediatrics.org/cgi/content/full/100/2/e3. 11. Mohan CG, Risucci DA, Casimir M, Gulrajani-LaCorte M. Comparison of analgesics in ameliorating the pain of circumcision. J Perinatol. 1998:18:13-19.
12. Serour F, Mandelberg A, Zabeeda D, Mori J. Ezra S. Efficacy of EMLA cream prior to dorsal penile nerve block for circumcision in children. ActaAnaesthesiol Scand 1998:42:260-263.
13. Kurtis PS. DeSilva HN, Bernstein BA. Malakh L, Schechter NL. A comparison of the Mogen and Gomco clamps in combination with dorsal penile nerve block in minimizing the pain of neonatal circumcision. Pediatrics. 1999:103:e23. Available at: http://www.pediatrics.org/cgi/content/full/103/2/e23.
14. Taddio A. Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet. 1997;349:599-603.
15. Newton CW, Mulnix N, Baer L, Bovee T. Plain and buffered lidocaine for neonatal circumcision. Obstet Gynecol. 1999;93:350-352.
16. Snellman LW, Stang HJ. Prospective evaluation of complications of dorsal penile nerve block for neonatal circumcision. Pediatrics. 1995;95:705-708.
17. Taddio A, Ohlsson A, Einarson TR, Stevens B, Koren G. A systematic review of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in neonates. Pediatrics. 1998:101(2):el. Available at: http://www.pediatrics.org/cgi/content/ full/101/2/el.
18. Brisman M, Llung BM. Otterbom I, Larsson LE, Andreasson SE. Methaemoglobin formation after the use of EMLA cream in term neonates. Acta Paediatr.1998. 87:1191-1194.
19. Taddio A, Ohlsson K. Ohlsson A. Lidocaine-prilocaine cream for analgesia during circumcision of newborn boys [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software, 1999:issue 3.